Oryzon Genomics to Participate in a Panel at the JMP Securities Life Sciences Conference and Present at the Jefferies 2017 Global Health Conference
BARCELONA, SPAIN and CAMBRIDGE MA.
Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that:
- Dr. Buesa will present at the Jefferies 2017 Global Healthcare Conference, June 9th 2017 at 12:30pm Eastern Time at The Grand Hyatt Hotel in New York;
- Dr. Buesa will participate in a panel discussion titled: “Epigenetics and Transcriptional Control - Regulating the Regulators” at The JMP Securities Life Sciences Conference, June 20th 2017 at 11 am Eastern Time at The St. Regis New York;
Click here to see the full Press Release